Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization

Dominic A M J Theuns1, Beat A Schaer2, Kadir Caliskan1

  • 1Dept. of Cardiology, Erasmus MC, Rotterdam, the Netherlands.

Insights

The Heart Failure (HF) Meta-score effectively predicts survival in patients receiving cardiac resynchronization defibrillators (CRT-D) for primary prevention. This score identifies high-risk individuals who may not benefit from CRT-D therapy.

Area of Science:

  • Cardiology
  • Medical Prognostics

Background:

  • The Heart Failure (HF) Meta-score's utility in predicting prognosis for primary prevention cardiac resynchronization defibrillators (CRT-D) patients is under investigation.
  • Considering competing risks of appropriate defibrillator shock versus mortality is crucial for accurate prognostic assessment.

Purpose of the Study:

  • To evaluate the performance of the HF Meta-score in predicting outcomes in patients with primary prevention CRT-D.
  • To assess the score's ability to predict mortality and the combined endpoint of death or appropriate implantable cardioverter-defibrillator (ICD) shock.

Main Methods:

  • Retrospective analysis of data from 648 consecutive patients across two centers.
  • Utilized the Fine-Gray model for competing risk regression analysis.
  • Primary endpoint: mortality; Secondary endpoint: time to first appropriate ICD shock or death without prior appropriate ICD shock.

Main Results:

  • Over a median of 5.2 years, 237 patients died. Five-year mortality incidence ranged from 12% to 53% across HF Meta-score quintiles.
  • The highest quintile showed a significantly higher mortality risk (HR 6.9) compared to the lowest.
  • The HF Meta-score demonstrated excellent calibration and discrimination for mortality prediction (C-statistic 0.76 at 1-year, 0.71 at 5-year).

Conclusions:

  • The HF Meta-score effectively predicts survival in heart failure patients treated with CRT-D for primary prevention.
  • The score is valuable for identifying patients with a poor prognosis despite CRT-D implantation.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
135
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
91
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
151
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
108
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
224